Rapamycin in Relapsed Acute Lymphoblastic Leukemia
Clinical trial NCT00874562 · COMPLETED
Trial details
- NCT number
- NCT00874562
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2009-11-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.